May is National High Blood Pressure Education Month. This yearly reminder is a good time to recognize the strides we as an industry have made in raising awareness about the impact of hypertension and reducing death and disability related to high blood pressure. Today, there is greater understanding of the fact that blood pressure (BP) measurement often provides an ideal starting point to help eliminate inefficiencies, achieve better clinical outcomes and lower costs.
The recent Systolic Blood Pressure Intervention Trial (SPRINT) study report showed that lowering systolic blood pressure (SBP) to less than 120 mmHg can reduce cardiovascular events by 25 percent for high-risk patients with hypertension.
The SPRINT results were in turn the basis for the updated guidelines from the American Heart Association (AHA) and the American College of Cardiology. These guidelines for the detection, prevention, management and treatment of high BP lower the traditional definition of high BP to account for complications that can occur at lower numbers and to allow for earlier intervention.
These developments were major accomplishments that moved the needle in terms of the quality of care provided and outcomes realized. However, there is still plenty of work to be done.